Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
- PMID: 9305510
Diagnostic criteria for dementia in clinical trials. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
Abstract
Some of the issues associated with standardizing the diagnosis of dementia in clinical trials are outlined. Deliberations of the Working Group on Diagnostic Criteria and their recommendations for future actions needed to develop a consensus are described.
Similar articles
-
Translation issues in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:61-4. Alzheimer Dis Assoc Disord. 1997. PMID: 9305520 No abstract available.
-
Activities of daily living as an outcome measure in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:6-7. Alzheimer Dis Assoc Disord. 1997. PMID: 9305507 No abstract available.
-
Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.Alzheimer Dis Assoc Disord. 1997;11 Suppl 3:34-8. Alzheimer Dis Assoc Disord. 1997. PMID: 9305514 No abstract available.
-
Assessment issues in clinical trials of tetrahydroaminoacridine and studies to alter decline in Alzheimer disease.Alzheimer Dis Assoc Disord. 1991;5 Suppl 1:S37-9. Alzheimer Dis Assoc Disord. 1991. PMID: 1781972 Review.
-
Asia regional meeting of the International Working Group for the Harmonization of Dementia Drug Guidelines: meeting report.Alzheimer Dis Assoc Disord. 2001 Apr-Jun;15(2):66-8. doi: 10.1097/00002093-200104000-00004. Alzheimer Dis Assoc Disord. 2001. PMID: 11403333 Review.
MeSH terms
Substances
LinkOut - more resources
Medical